Piramal Enterprises is currently trading at Rs. 1805.05, up by 53.05 points or 3.03% from its previous closing of Rs. 1752.00 on the BSE.
The scrip opened at Rs. 1799.00 and has touched a high and low of Rs. 1819.25 and Rs. 1763.75 respectively. So far 22922 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 2008.20 on 03-Mar-2021 and a 52 week low of Rs. 805.60 on 22-Apr-2020.
Last one week high and low of the scrip stood at Rs. 1868.00 and Rs. 1741.00 respectively. The current market cap of the company is Rs. 40725.45 crore.
The promoters holding in the company stood at 46.06%, while Institutions and Non-Institutions held 39.13% and 14.80% respectively.
Piramal Enterprises’ subsidiary company -- Piramal Pharma (PPL) has entered into an agreement to acquire a 100% stake in Hemmo Pharmaceuticals (Hemmo) for an upfront consideration of Rs 775 crore and earn-outs linked to achievement of milestones. Consequent to this Acquisition, Hemmo would become a wholly owned subsidiary of PPL. Hemmo is one of India’s largest manufacturers of synthetic peptides with a legacy of more than thirty eight years in business supplying peptide products and custom peptide synthesis.
Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.
Company Name | CMP |
---|---|
Bajaj Finance | 7240.35 |
Shriram Finance | 2360.20 |
Aditya Birla Capital | 175.70 |
SBI Cards AndPayment | 682.45 |
Chola Invest & Fin. | 1163.70 |
View more.. |